Novartis Safety Efforts Challenged In NJ Zometa Trial

Law360, New York (May 2, 2013, 11:01 PM EDT) -- Counsel for a woman suing Novartis Pharmaceutical Corp. in New Jersey mass tort litigation over its bone drug Zometa grilled current and former employees of the life sciences giant on Thursday in a bid to show that the company fell short in communicating the medication's ties to dead jaw bone.

Witnesses called by plaintiff Beverly Meng on Thursday included Linda Weiss, a former medical information specialist with the company. Meng attorney John J. Beins questioned Weiss about a March 2004 email that urged caution about using...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.